Resources Contact Us Home
Intracorporeal medicaments for photodynamic treatment of disease

Image Number 3 for United States Patent #7863047.

New intracorporeal photodynamic medicaments and certain medical uses and methods for use of such photodynamic medicaments for treatment of disease in human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs, the mouth and digestive tract and related organs, the urinary and reproductive tracts and related organs, the respiratory tract and related organs, the circulatory system and related organs, the head and neck, the endocrine and lymphoreticular systems and related organs, various other tissues, such as connective tissues and various tissue surfaces exposed during surgery, as well as various tissues exhibiting microbial or parasitic infection. In another preferred embodiment, such medicaments are produced in various formulations including liquid, semisolid, solid or aerosol delivery vehicles.

  Recently Added Patents
Methods for determining decoding order in a MIMO system with successive interference cancellation
Non-volatile memory and method having efficient on-chip block-copying with controlled error rate
Providing a feedback loop in a low latency serial interconnect architecture
Methods and systems providing desktop search capability to software application
Deflection device for a scanner with Lissajous scanning
Thermochromic microparticles, dispersions thereof, and manufacturing method thereof, as well as light-modulating coatings, light-modulating films and light-modulating inks
Method and apparatus for cutting high quality internal features and contours
  Randomly Featured Patents
Vault caddy
Metallic separator for fuel cell
Back plate with a grounding member for an electric apparatus
Logic gate system design
Cyclopentanone derivatives
Use of heme-containing proteins as stabilizers for enzyme-labeled immunoreactants
Programmable anti-fuse structures with conductive material islands
Method for removing burrs from workpieces
Position-based integrated motion controlled curve sawing
N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics